logo

For the Inventor, By the Inventor

Flemington, NJ, United States of America

Virginia L Pulito

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Centocor, Inc.. Active years: 2000-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Virginia L Pulito. Retrieved from https://idiyas.com/inventor/virginia-l-pulito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 40.0

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:

goldMedal4 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal4 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents
bronzeMedal2 out of 144 
 
Centocor, Inc.
 patents

Years Active: 2000-2010

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7777018 - CDR-grafted anti-tissue factor antibodies and methods of use thereof (2010-08-17),
2. 7544790 - CDR-grafted anti-tissue factor antibodies and methods of uses there of (2009-06-09),
3. 7517885 - Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds (2009-04-14),
4. 7482348 - Piperazinyl substituted cyclohexane-1,4-diamines (2009-01-27),
5. 7470711 - Piperidinyl substituted cyclohexane-1,4-diamines (2008-12-30),
6. 7459557 - Substituted isoindole-1,3-diones (2008-12-02),
7. 7235380 - CDR-grafted anti-tissue factor antibodies and methods of use thereof (2007-06-26),
8. 6890921 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia (2005-05-10),
9. 6593474 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia (2003-07-15),
10. 6071915 - Arylsubstituted piperazines useful in the treatment of benign prostatic (2000-06-06),

Title: Virginia L Pulito: Innovator in Anticoagulant Antibodies

Introduction

Virginia L Pulito is a prominent inventor based in Flemington, NJ (US). She has made significant contributions to the field of biomedical research, particularly in the development of innovative antibodies for therapeutic use. With a total of 10 patents, her work has had a profound impact on the treatment of thrombotic diseases.

Latest Patents

Among her latest inventions are the CDR-grafted anti-tissue factor antibodies and methods of use thereof. This invention provides CDR-grafted antibodies against human tissue factor that retain the high binding affinity of rodent monoclonal antibodies against tissue factor but have reduced immunogenicity. The present humanized antibodies are potent anticoagulants and are thus useful in the treatment and prophylaxis of human thrombotic disease. The invention also includes methods of making the CDR-grafted antibodies and pharmaceutical compositions for the attenuation or prevention of coagulation.

Career Highlights

Virginia has worked with notable companies such as Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical industry.

Collaborations

Throughout her career, Virginia has collaborated with esteemed colleagues, including George Chiu and Peter J Connolly. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Virginia L Pulito is a trailblazer in the field of anticoagulant antibodies, with a strong portfolio of patents that reflect her innovative spirit and dedication to improving human health. Her contributions continue to influence the development of effective treatments for thrombotic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…